Bernard Reen
Interventional Cardiology · Charlotte, NCNPI 1740288042
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Abbott at 32.7% of the total. Reporting peaked in 2019 at $1,314 and has fallen 95.9% since, to $54 in 2025. That places this record below the midpoint for interventional cardiology clinicians in NC, where the typical reported total is $5,390.
Across 165 payments — averaging $21.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Boston Scientific$568
- AstraZeneca$387
- Teleflex LLC$278
- E.r. Squibb & Sons, L.L.C.$195
- Edwards Lifesciences$187
- plus $785 from 14 others
Across 6 payments — averaging $2075.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$12K
What the payments were for
- Food & beverage$3,569100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 88 | $1,167 |
| Boston Scientific | 17 | $568 |
| AstraZeneca | 8 | $387 |
| Teleflex LLC | 2 | $278 |
| E.r. Squibb & Sons, L.L.C. | 8 | $195 |
| Edwards Lifesciences | 2 | $187 |
| Cardiovascular Systems Inc. | 8 | $153 |
| Johnson & Johnson | 9 | $142 |
| Amgen | 7 | $131 |
| Abiomed | 4 | $86 |
| Cardiva Medical, Inc. | 1 | $71 |
| Novartis | 2 | $44 |
| EKOS Corporation | 1 | $26 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $26 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Medtronic | 1 | $18 |
| Bayer | 1 | $17 |
| Asahi Intecc USA, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GUIDELINER$278
- CROSSBOSS$160
- FARXIGA$125
- Watchman$121
- Edwards SAPIEN 3 Transcatheter Heart Valve$120
- XIENCE SIERRA$112
- Xience Sierra Coronary Stent$105
- ELIQUIS$102
How this compares
$3,569 in reported general payments places this provider in the 30th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Other interventional cardiology in Charlotte
- Oluseun AlliCharlotte$485K
- Glen FandettiCharlotte$46K
- John PasquiniCharlotte$32K
- Aamer QureshiCharlotte$27K
- Daniel PuCharlotte$23K
- Nyal BorgesCharlotte$18K
- George AdamsGarner$4.1M
- Paul MahoneyGreenville$1.7M
- Ravish SacharRaleigh$1.6M
- Patrick SimpsonPinehurst$579K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.